Editorial Board — Medscape Nephrology

Board Members

 

Board Member Details

Rajiv Agarwal, MD
Rajiv Agarwal, MD

Professor of Medicine, Indiana University School of Medicine; Staff Physician, Indiana University, Indianapolis, Indiana

Rajiv Agarwal, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Akebia Therapeutics; Relypsa Inc; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; sanofi-aventis; AstraZeneca Pharmaceuticals LP;
Received income in an amount equal to or greater than $250 from: Akebia Therapeutics; Relypsa Inc; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; sanofi-aventis; AstraZeneca Pharmaceuticals LP

Jeffrey S. Berns, MD
Jeffrey S. Berns, MD

Associate Dean for Graduate Medical Education, University of Pennsylvania Health System; Nephrology Fellowship Program Director, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Jeffrey S. Berns, MD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: UpToDate; American Journal of Kidney Diseases; American Board of Internal Medicine

Francesco Locatelli, MD

Emeritus Director, Department of Nephrology, Alessandro Manzoni Hospital, Lecco, Italy

Francesco Locatelli, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisor for: Akebia Therapeutics; Amgen Inc.
Serve(d) as a speaker for: AbbVie; Amgen Inc.; Bayer HealthCare Pharmaceuticals; Roche; Vifor Pharma; Fresnius SE & Co.

Donal J. O'Donoghue, MBChB, FRCP
Donal O'Donoghue, MB, ChB

Professor, Manchester University Medical School; Medical Director, Citylabs, Manchester, England

Donal J. O'Donoghue, MBChB, FRCP, has disclosed no relevant financial relationships.

Richard A. Sherman, MD
Richard A. Sherman, MD

Professor Emeritus, Robert Wood Johnson Medical School, New Brunswick, New Jersey

Richard A. Sherman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Merck & Co. Inc
Received income in an amount equal to or greater than $250 from: Merck & Co. Inc.

Lynda A. Szczech, MD, MSE
Lynda A. Szczech, MD

Nephrologist, Durham Nephrology Associates, Durham, North Carolina

Lynda Szczech, MD, MSE, has disclosed the following relevant financial relationship:
Employee of: FibroGen

Matthew R. Weir, MD
Matthew R. Weir, MD

Professor of Medicine; Director, Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland

Matthew R. Weir, MD, has disclosed the following relevant financial relationships:
Serve(d) as scientific advisor for: Akebia Therapeutics; Relypsa, Inc.; Bayer HealthCare Pharmaceuticals; Merck Sharp & Dohme Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals, LP; Vifor Pharma; Boston Scientific; Reata Pharmaceuticals, Inc.; AbbVie